Combined Impact of Mean and Variability of Non-HDL-Cholesterol on Cardiovascular Risk in Patients Undergoing Hemodialysis

被引:0
|
作者
Lee, Hanbi [1 ]
Yang, Chul Woo [1 ]
Chung, Byung Ha [1 ]
机构
[1] Seoul St Marys Hosp, Seoul, South Korea
来源
关键词
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
SA-PO366
引用
收藏
页码:705 / 706
页数:2
相关论文
共 50 条
  • [41] Composition of non-HDL cholesterol and residual cardiovascular risk in secondary prevention
    Hansen, M. K.
    Olesen, K. K. W.
    Thrane, P. G.
    Gyldenkerne, C.
    Stoedkilde-Joergensen, N.
    Andersen, M. H.
    Maeng, M.
    Mortensen, M. B.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [42] A Retrospective Analysis of Non-HDL Cholesterol: For Improved Cardiovascular Risk Assessment
    Khan, Sohail Rafi
    Mukhtar, Ana
    Ahmed, Altaf
    ANNALS ABBASI SHAHEED HOSPITAL & KARACHI MEDICAL & DENTAL COLLEGE, 2015, 20 (02): : 97 - 102
  • [43] Impact of hemoglobin variability on cardiovascular mortality in maintenance hemodialysis patients
    Fu-Jun Lin
    Xi Zhang
    Lu-Sheng Huang
    Gang Ji
    Hai-Dong Huang
    Yun Xie
    Geng-Ru Jiang
    Xin Zhou
    Wei Lu
    International Urology and Nephrology, 2018, 50 : 1703 - 1712
  • [44] Impact of hemoglobin variability on cardiovascular mortality in maintenance hemodialysis patients
    Lin, Fu-Jun
    Zhang, Xi
    Huang, Lu-Sheng
    Ji, Gang
    Huang, Hai-Dong
    Xie, Yun
    Jiang, Geng-Ru
    Zhou, Xin
    Lu, Wei
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2018, 50 (09) : 1703 - 1712
  • [45] Comparison of non-HDL-cholesterol versus triglycerides-to-HDL-cholesterol ratio in relation to cardiometabolic risk factors and preclinical organ damage in overweight/obese children: The CARITALY study
    Di Bonito, P.
    Valerio, G.
    Grugni, G.
    Licenziati, M. R.
    Maffeis, C.
    Manco, M.
    del Giudice, E. Miraglia
    Pacifico, L.
    Pellegrin, M. C.
    Tomat, M.
    Baroni, M. G.
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2015, 25 (05) : 489 - 494
  • [46] Apolipoprotein B, non-HDL cholesterol and LDL cholesterol for identifying individuals at increased cardiovascular risk
    Holewijn, S.
    den Heijer, M.
    Swinkels, D. W.
    Stalenhoef, A. F. H.
    de Graaf, J.
    JOURNAL OF INTERNAL MEDICINE, 2010, 268 (06) : 567 - 577
  • [47] Intestinal Cholesterol Absorption, Treatment With Atorvastatin, and Cardiovascular Risk in Hemodialysis Patients
    Silbernagel, Guenther
    Fauler, Guenter
    Genser, Bernd
    Drechsler, Christiane
    Krane, Vera
    Scharnagl, Hubert
    Grammer, Tanja B.
    Baumgartner, Iris
    Ritz, Eberhard
    Wanner, Christoph
    Maerz, Winfried
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (21) : 2291 - 2298
  • [48] Impact Of Pemafibrate On Triglyceride To Hdl-cholesterol Ratio And Risk Of Adverse Cardiovascular Events
    Imamura, Teruhiko
    Kinugawa, Koichiro
    JOURNAL OF CARDIAC FAILURE, 2023, 29 (04) : 590 - 590
  • [49] A simple multiplier to calculate the impact of HDL cholesterol on cardiovascular risk estimation using SCORE
    Descamps, Olivier S.
    Cooney, Marie Therese
    De Backer, Guy
    Graham, Ian
    ATHEROSCLEROSIS, 2012, 222 (02) : 564 - 566
  • [50] Non HDL Cholesterol: could be e new cardiovascular disease risk stratification factor?
    Valaperta, S.
    Esposito, S. Apassiti
    Moioli, V.
    Picciau, A.
    Saiaci, C.
    Marozzi, R.
    Alessio, M.
    CLINICAL CHEMISTRY, 2024, 70